LUTS: Lower Urinary Tract Symptoms最新文献

筛选
英文 中文
Through the zipper or pants down: Does it change uroflowmetry parameters in healthy males? 通过拉链或裤子:它会改变健康男性的尿流测量参数吗?
IF 1.3 4区 医学
LUTS: Lower Urinary Tract Symptoms Pub Date : 2022-04-05 DOI: 10.1111/luts.12442
Muhammet İrfan Dönmez, Mehmet Serkan Özkent, Mustafa Bilal Hamarat, Mehmet Kocalar
{"title":"Through the zipper or pants down: Does it change uroflowmetry parameters in healthy males?","authors":"Muhammet İrfan Dönmez,&nbsp;Mehmet Serkan Özkent,&nbsp;Mustafa Bilal Hamarat,&nbsp;Mehmet Kocalar","doi":"10.1111/luts.12442","DOIUrl":"10.1111/luts.12442","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To evaluate if voiding through the zipper or voiding pants down would make any difference with regard to uroflowmetry parameters and postvoiding residual urine (PVR) volumes in healthy males with no lower urinary tract symptoms (LUTS).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Healthy males over 18 years of age with no LUTS were prospectively evaluated using a uroflowmetry test. Each individual was asked to void through the zipper (group 1) and pants down (group 2) at different times. The uroflowmetry test was repeated if the voided volume did not exceed 150 mL. Uroflowmetry results such as voided volume, maximum flow rate (Qmax), average flow rate (Qave), and duration of voiding were noted. PVR volume was assessed using ultrasonography. Electromyography was not used. Data are shown as mean ± standard deviation. For statistical analysis, a paired <i>t</i> test was used to analyze parametric parameters.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 44 males were enrolled. The median age of the individuals was 24 (range 18-44 years). There were no statistically significant differences between the two measurements in terms of voided volume (307 ± 121 mL vs 325 ± 145 mL, <i>P</i> = .365) and duration of voiding (25 ± 11 s vs 23.8 ± 11.6 s, <i>P</i> = .526). However, there were statistically significant differences in Qmax (26.6 ± 6.7 mL/s vs 30.0 ± 8.2 mL/s, <i>P</i> = .001), Qave (14.4 ± 3.6 mL/s vs 16.2 ± 5.1 mL/s, <i>P</i> = .009), and PVR volumes (23.9 ± 19.4 mL vs 3.9 ± 9.6 mL, <i>P</i> = .0001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Voiding pants down shows higher flow rates and lower PVR than voiding through the zipper in individuals with no LUTS. Future studies with a larger number of individuals (including those with LUTS) and a broader age range cohort are required for solid conclusions.</p>\u0000 </section>\u0000 </div>","PeriodicalId":18028,"journal":{"name":"LUTS: Lower Urinary Tract Symptoms","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80192434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare cases of vesicouterine fistula 膀胱外瘘罕见病例
IF 1.3 4区 医学
LUTS: Lower Urinary Tract Symptoms Pub Date : 2022-03-27 DOI: 10.1111/luts.12440
Maulidina Medika Rahmita, Arry Rodjani, Irfan Wahyudi, Fina Widia
{"title":"Rare cases of vesicouterine fistula","authors":"Maulidina Medika Rahmita,&nbsp;Arry Rodjani,&nbsp;Irfan Wahyudi,&nbsp;Fina Widia","doi":"10.1111/luts.12440","DOIUrl":"10.1111/luts.12440","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Case</h3>\u0000 \u0000 <p>Vesicouterine fistula (VUF) is the rarest form of genitourinary fistulas. As lower-segment cesarean section becomes a more common mode of delivery, they have become the leading cause of VUF formation. We present four VUF patients with varied symptoms such as menouria, amenorrhea, with or without urinary incontinence. We diagnosed all of our cases through cystoscopy in conjunction with methylene blue dye test or hysteroscopy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Outcome</h3>\u0000 \u0000 <p>We successfully repaired VUF in three open surgery instances and one laparoscopic case. To diagnose VUF, cystoscopy and hysteroscopy are still the gold standard. An expert surgeon's open or laparoscopic repair is effective and safe. The patients no longer experienced incontinence, cyclical hematuria (menouria), discomfort, or sexual dysfunction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Cystoscopy and hysteroscopy remain the gold standard tool in diagnosing VUF. Open or laparoscopic repair performed by an experienced surgeon is an effective and safe technique with a successful outcome.</p>\u0000 </section>\u0000 </div>","PeriodicalId":18028,"journal":{"name":"LUTS: Lower Urinary Tract Symptoms","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81473002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Prevalence and factors associated with urinary incontinence in female crossfitters: A cross-sectional study 女性混合健身者尿失禁的患病率及相关因素:一项横断面研究
IF 1.3 4区 医学
LUTS: Lower Urinary Tract Symptoms Pub Date : 2022-03-22 DOI: 10.1111/luts.12437
Elizabete de Souza Pereira, Ana Paula de Lima Ferreira, Milene de Oliveira Almeida, Cinthia Silva Barbosa, Gleyce de Melo Falcão Monteiro, Leila Barbosa, Andrea Lemos
{"title":"Prevalence and factors associated with urinary incontinence in female crossfitters: A cross-sectional study","authors":"Elizabete de Souza Pereira,&nbsp;Ana Paula de Lima Ferreira,&nbsp;Milene de Oliveira Almeida,&nbsp;Cinthia Silva Barbosa,&nbsp;Gleyce de Melo Falcão Monteiro,&nbsp;Leila Barbosa,&nbsp;Andrea Lemos","doi":"10.1111/luts.12437","DOIUrl":"10.1111/luts.12437","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To determine the prevalence and factors associated with urinary incontinence (UI) in female crossfitters.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This is a cross-sectional study. Data were collected using assessment forms: Knowledge, Attitude and Practice survey for young female athletes; Incontinence Severity Index; and International Consultation on Incontinence Questionnaire for UI. Descriptive analysis was conducted to obtain absolute and relative frequencies, means and 95% confidence intervals (95% CI). Multivariate analysis was carried out to determine the association between UI and sociodemographic, gynecological-obstetric, and anthropometric variables, associated morbidities, previous history and physical activity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Prevalence of UI, in the 189 included volunteers, was 38.6% and the most frequent type was stress UI (69.9%). A total of 72.6% of incontinent women reported urine loss during CrossFit training. Knowledge (53.4%) and attitude (86.2%) regarding UI were generally adequate, while prevention, management and treatment were inadequate (96.3%). The predominant characteristics of UI were frequency of once a week or less (74.0%), in small amounts (86.3%), mild intensity (57.5%) and slight impact on quality of life (64.3%). In multivariate analysis, no variable was significantly associated with UI.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The prevalence of UI in female crossfitters was 38.6%. The factors investigated did not contribute to the development of UI.</p>\u0000 </section>\u0000 </div>","PeriodicalId":18028,"journal":{"name":"LUTS: Lower Urinary Tract Symptoms","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40314227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for pharmacotherapy for storage symptoms after transurethral resection of the prostate in patients with benign prostatic hyperplasia 良性前列腺增生患者经尿道前列腺切除术后药物治疗积存症状的危险因素
IF 1.3 4区 医学
LUTS: Lower Urinary Tract Symptoms Pub Date : 2022-03-21 DOI: 10.1111/luts.12438
Cheng-Han Tsai, Yu-Hua Fan, Alex T. L. Lin, William J. Huang
{"title":"Risk factors for pharmacotherapy for storage symptoms after transurethral resection of the prostate in patients with benign prostatic hyperplasia","authors":"Cheng-Han Tsai,&nbsp;Yu-Hua Fan,&nbsp;Alex T. L. Lin,&nbsp;William J. Huang","doi":"10.1111/luts.12438","DOIUrl":"10.1111/luts.12438","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Postoperative persistence of storage symptoms after transurethral resection of the prostate (TURP) is bothersome, and evidence of its cause is sparse. We sought to analyze risk factors for using antimuscarinics or beta-3 agonists after TURP in benign prostatic hyperplasia (BPH) patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>BPH patients who underwent TURP and were followed up for &gt;6 months after surgery were retrospectively enrolled. Postoperative pharmacotherapy for storage symptoms was defined as the prescription of antimuscarinics or beta-3 agonists within 3 months after TURP for &gt;3 months. Preoperative and perioperative variables were evaluated for their effect on the postoperative prescription of antimuscarinics or beta-3 agonists.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of the 376 patients, 45 (12.0%) received postoperative pharmacotherapy for storage symptoms. Patients who underwent bipolar TURP were significantly more likely to receive postoperative pharmacotherapy than those who underwent monopolar TURP (15.7% vs 6.9%; <i>P</i> = 0.01). Significantly more patients with intravesical prostatic protrusions &gt;1 cm used postoperative pharmacotherapy than those with protrusions of ≤1 cm (14.4% vs 5.2% respectively; <i>P</i> = 0.02). Multivariate logistic regression analysis revealed age &gt;75 years (odds ratio [OR] 3.04; 95% CI 1.29-7.16; <i>P</i> = 0.011), intravesical prostatic protrusion &gt;1 cm (OR, 3.48; 95% CI, 1.32-9.15; <i>P</i> = 0.012), and bipolar transurethral resection (OR 4.25; 95% CI 1.53-11.80; <i>P</i> = 0.005) as significant risk factors for postoperative pharmacotherapy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Advanced age, intravesical prostatic protrusion, and bipolar TURP were significantly associated with postoperative pharmacotherapy for storage symptoms after TURP in BPH patients. Therefore, patients with these risk factors might be informed about the risk of postoperative storage symptoms that may require medications after TURP.</p>\u0000 </section>\u0000 </div>","PeriodicalId":18028,"journal":{"name":"LUTS: Lower Urinary Tract Symptoms","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40311400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of diagnostic serum biomarkers for Hunner-type interstitial cystitis hunner型间质性膀胱炎诊断血清生物标志物的鉴定
IF 1.3 4区 医学
LUTS: Lower Urinary Tract Symptoms Pub Date : 2022-03-20 DOI: 10.1111/luts.12439
Kazumasa Torimoto, Tomohiro Ueda, Masato Kasahara, Akihide Hirayama, Chie Matsushita, Yoshihiro Matsumoto, Daisuke Gotoh, Yasushi Nakai, Makito Miyake, Katsuya Aoki, Kiyohide Fujimoto
{"title":"Identification of diagnostic serum biomarkers for Hunner-type interstitial cystitis","authors":"Kazumasa Torimoto,&nbsp;Tomohiro Ueda,&nbsp;Masato Kasahara,&nbsp;Akihide Hirayama,&nbsp;Chie Matsushita,&nbsp;Yoshihiro Matsumoto,&nbsp;Daisuke Gotoh,&nbsp;Yasushi Nakai,&nbsp;Makito Miyake,&nbsp;Katsuya Aoki,&nbsp;Kiyohide Fujimoto","doi":"10.1111/luts.12439","DOIUrl":"10.1111/luts.12439","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Diagnosis of Hunner-type interstitial cystitis (HIC) relies on the ability to identify Hunner lesions endoscopically, which can lead to storage symptom misdiagnosis. Here, we examined serum biomarkers for HIC and verified their utility.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Based on the previous definition of the Japanese guidelines, which did not distinguish HIC and non-HIC diseases, we searched for serum biomarkers in 25 patients with interstitial cystitis (IC) and 25 control participants using metabolomics during 2013–2014. In 2019, we conducted a validation study in HIC and control groups. Serum samples were analyzed using liquid chromatography–tandem mass spectrometry, and candidate biomarker concentrations were compared between the groups using Mann–Whitney test.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Metabolomics targeted 678 metabolites and revealed that the levels of 14 lysolipids, seven γ-glutamyl amino acids, and two monoacylglycerols were significantly different between the IC and control groups. The following metabolites were selected from each metabolite category as candidates: 1-linoleoylglycerophosphocholine (1-linoleloyl-GPC [18:2]), γ-glutamylisoleucine (γ-Glu-Ile), and 1-arachidonylglycerol (1-AG). The serum concentrations of 1-linoleoyl-GPC (18:2) in the HIC and control groups were 27 920 ± 6261 and 40 360 ± 1514 ng/mL (<i>P</i> = 0.0003), respectively. The serum concentrations of γ-Glu-Ile and 1-AG were not significantly different between the groups. When the cut-off value of 1-linoleoyl-GPC (18:2) was set at 28 400 ng/mL, the sensitivity and specificity were 68% and 84%, respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Serum 1-linoleoyl-GPC (18:2) is a candidate diagnostic biomarker for HIC. Additional studies on whether this biomarker can distinguish HIC from other diseases with high urination frequency are required for its clinical use.</p>\u0000 </section>\u0000 </div>","PeriodicalId":18028,"journal":{"name":"LUTS: Lower Urinary Tract Symptoms","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74429867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Urodynamically proven lower urinary tract dysfunction in children after COVID‐19: A case series 经尿动力学证实的COVID - 19后儿童下尿路功能障碍:一个病例系列
IF 1.3 4区 医学
LUTS: Lower Urinary Tract Symptoms Pub Date : 2022-03-15 DOI: 10.1111/luts.12436
I. Selvi, M. Dönmez, O. Ziylan, T. Oktar
{"title":"Urodynamically proven lower urinary tract dysfunction in children after COVID‐19: A case series","authors":"I. Selvi, M. Dönmez, O. Ziylan, T. Oktar","doi":"10.1111/luts.12436","DOIUrl":"https://doi.org/10.1111/luts.12436","url":null,"abstract":"Since the declaration of COVID‐19 as a pandemic, other unexpected symptoms related to the infection besides the respiratory system have been reported. Although a few case reports have revealed that adult patients with COVID‐19 also complained of urinary frequency and nocturia, the exact pathophysiology is still unclear. In this case series, we present three children aged 14 to 17 years with urodynamically proven lower urinary tract dysfunction (LUTD) following COVID‐19.","PeriodicalId":18028,"journal":{"name":"LUTS: Lower Urinary Tract Symptoms","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82945915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Effects of saw palmetto extract on the vanilloid receptor TRPV1. 锯棕榈提取物对香草素受体TRPV1的影响。
IF 1.3 4区 医学
LUTS: Lower Urinary Tract Symptoms Pub Date : 2022-03-01 Epub Date: 2021-10-21 DOI: 10.1111/luts.12413
Shizuo Yamada, Yoshihisa Kato
{"title":"Effects of saw palmetto extract on the vanilloid receptor TRPV1.","authors":"Shizuo Yamada,&nbsp;Yoshihisa Kato","doi":"10.1111/luts.12413","DOIUrl":"https://doi.org/10.1111/luts.12413","url":null,"abstract":"<p><strong>Objective: </strong>Transient receptor potential vanilloid subtype 1 (TRPV1) may play a significant role in the pathophysiology of the bladder. The present study investigated the effects of the herbal product, saw palmetto extract (SPE) on TRPV1-mediated Ca<sup>2+</sup> influx and specific [<sup>3</sup> H]resiniferatoxin ([<sup>3</sup> H]RTX) binding to TRPV1 in HEK293 cells expressing TRPV1 (HEK293VR11 cells).</p><p><strong>Methods: </strong>Ca<sup>2+</sup> influx induced by and the direct binding activity of TRPV1 were measured using a method with Fura 2-AM, a cytoplasmic calcium indicator, and a radioligand binding assay using a [<sup>3</sup> H]RTX, respectively.</p><p><strong>Results: </strong>SPE did not markedly affect Ca<sup>2+</sup> influx in HEK293VR11 cells; however, it significantly inhibited capsaicin-induced increases in Ca<sup>2+</sup> influx in these cells. The specific binding of [<sup>3</sup> H]RTX in HEK293VR11 cells was saturable with K<sub>d</sub> value of 120 ± 7 pM and B<sub>max</sub> of 1.07 ± 0.10 fmol/mg protein, and was inhibited by low concentrations of non-labeled RTX with K<sub>i</sub> of 60.1 ± 7.6 nM. These results confirmed the pharmacological specificity of specific binding sites of [<sup>3</sup> H]RTX to TRPV1 in HEK293VR11 cells. SPE inhibited the specific binding of [<sup>3</sup> H]RTX in a concentration-dependent manner, with K<sub>i</sub> of 24.2 ± 1.4 μg/mL.</p><p><strong>Conclusions: </strong>The present study demonstrated for the first time, that SPE inhibited capsaicin-induced Ca<sup>2+</sup> influx with binding to TRPV1 in HEL293VR11 cells. These results will contribute to a more detailed understanding of the pharmacological effects of SPE on urinary dysfunction.</p>","PeriodicalId":18028,"journal":{"name":"LUTS: Lower Urinary Tract Symptoms","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39536461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Efficacy of vibegron in patients with overactive bladder: Multicenter prospective study of real-world clinical practice in Japan, SCCOP study 19-01. vibegron对膀胱过动症患者的疗效:日本临床实践的多中心前瞻性研究,SCCOP研究19-01。
IF 1.3 4区 医学
LUTS: Lower Urinary Tract Symptoms Pub Date : 2022-03-01 Epub Date: 2021-10-28 DOI: 10.1111/luts.12417
Kimihito Tachikawa, Yuki Kyoda, Fumimasa Fukuta, Ko Kobayashi, Naoya Masumori
{"title":"Efficacy of vibegron in patients with overactive bladder: Multicenter prospective study of real-world clinical practice in Japan, SCCOP study 19-01.","authors":"Kimihito Tachikawa,&nbsp;Yuki Kyoda,&nbsp;Fumimasa Fukuta,&nbsp;Ko Kobayashi,&nbsp;Naoya Masumori","doi":"10.1111/luts.12417","DOIUrl":"https://doi.org/10.1111/luts.12417","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the efficacy and safety of vibegron in patients with overactive bladder (OAB) in real-world clinical practice in Japan.</p><p><strong>Methods: </strong>This multicenter, prospective, non-controlled study consecutively enrolled patients with OAB determined by an OAB symptom score (OABSS) of three points or more and a question 3 (urgency) score of two points or more. A total of 212 patients from 43 institutions were recruited from January 2019 through March 2020. Vibegron, 50 mg, was administrated daily for 8 weeks as first-line monotherapy (first-line group, FL), monotherapy switching from antimuscarinics (post-antimuscarinic group, PA) or mirabegron (post-mirabegron group, PM) and combination therapy with antimuscarinics (add-on group). The OABSS was collected at baseline and every 2 weeks. Adverse events were recorded at every visit.</p><p><strong>Results: </strong>Of the 212 patients registered, 188 (male 76, female 112) were eligible for analysis (124 in the FL group, 27 in PA, 29 in PM, and eight in the add-on group). The add-on group was excluded from further analysis due to its small number. The OABSS (mean ± SD) showed significant improvement in all groups (FL; 8.8 ± 2.5, 3.8 ± 2.8, PM; 9.4 ± 2.2, 4.5 ± 4.0, PM; 8.9 ± 2.5, 4.7 ± 3.3 at 0 and 8 weeks, respectively). The overall incidence of adverse events was 25%. No grade 3 or higher adverse events were observed.</p><p><strong>Conclusions: </strong>In the real-world clinical setting, vibegron is effective and well-tolerated by OAB patients, including those switching therapy from antimuscarinics and mirabegron.</p>","PeriodicalId":18028,"journal":{"name":"LUTS: Lower Urinary Tract Symptoms","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39573318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Interventional management and surgery of neurogenic lower urinary tract dysfunction in patients with chronic spinal cord injury: A urologist's perspective 慢性脊髓损伤患者神经源性下尿路功能障碍的介入治疗和手术:泌尿科医生的观点
IF 1.3 4区 医学
LUTS: Lower Urinary Tract Symptoms Pub Date : 2022-03-01 DOI: 10.1111/luts.12434
Sheng-Fu Chen, Hann-Chorng Kuo
{"title":"Interventional management and surgery of neurogenic lower urinary tract dysfunction in patients with chronic spinal cord injury: A urologist's perspective","authors":"Sheng-Fu Chen,&nbsp;Hann-Chorng Kuo","doi":"10.1111/luts.12434","DOIUrl":"10.1111/luts.12434","url":null,"abstract":"<p>Neurogenic lower urinary tract dysfunction (NLUTD) caused by spinal cord injury (SCI) is challenging for urologists. NLUTD not only affects the quality of life but also endangers the upper urinary tract of patients with chronic SCI. Considering that the bladder and urethral function change with time, regular follow-up of NLUTD is necessary, and any complication should be adequately treated. The first priority of bladder management in patients with chronic SCI manifesting NLUTD should be renal function preservation, followed by the normalization of lower urinary tract function. The quality of life should also be assessed. Patients who have a high risk for impaired renal function should be more frequently identified and investigated. Conservative treatment and pharmacological therapy should be started as early as possible. Intravesical or urethral injections of botulinum toxin A is an alternative treatment for refractory NLUTD. When surgical intervention is necessary, less invasive and reversible procedures should be considered first. Improving patients' quality of life and willingness to undergo bladder management is the most important aspect of treatment.</p>","PeriodicalId":18028,"journal":{"name":"LUTS: Lower Urinary Tract Symptoms","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83625195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The effects of choreito on a model of nocturnal polyuria using Dahl salt-sensitive rats. 舞蹈病对达尔盐敏感大鼠夜间多尿模型的影响。
IF 1.3 4区 医学
LUTS: Lower Urinary Tract Symptoms Pub Date : 2022-03-01 Epub Date: 2021-11-18 DOI: 10.1111/luts.12418
Takashi Iwamoto, Kazumasa Torimoto, Daisuke Gotoh, Shunta Hori, Yasushi Nakai, Makito Miyake, Yohei Tokita, Ryohei Kobayashi, Katsuya Aoki, Kiyohide Fujimoto
{"title":"The effects of choreito on a model of nocturnal polyuria using Dahl salt-sensitive rats.","authors":"Takashi Iwamoto,&nbsp;Kazumasa Torimoto,&nbsp;Daisuke Gotoh,&nbsp;Shunta Hori,&nbsp;Yasushi Nakai,&nbsp;Makito Miyake,&nbsp;Yohei Tokita,&nbsp;Ryohei Kobayashi,&nbsp;Katsuya Aoki,&nbsp;Kiyohide Fujimoto","doi":"10.1111/luts.12418","DOIUrl":"https://doi.org/10.1111/luts.12418","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to determine whether Dahl salt-sensitive rats fed a high-salt diet would show features of nocturia due to nocturnal polyuria and to examine the efficacy of choreito (CRT) on nocturnal polyuria.</p><p><strong>Methods: </strong>Dahl salt-sensitive rats were divided into three groups. Group A was fed a 4% salt diet, group B a 2% salt diet, and group C a normal 0.3% salt diet. In groups α and β, other rats were further divided into two groups: The rats in group α were fed a 2% salt plus 3% CRT diet, and those in group β, were fed a 2% salt diet. Each rat was placed in an individual metabolic cage for 24 hours every week for 6 weeks. Water intake, urine production, voiding frequency, and voided volume per micturition were recorded.</p><p><strong>Results: </strong>The systolic blood pressure increased in the group fed a 4% salt diet compared to groups fed with a 2% and 0.3% salt diet. The urinary volume was higher in the groups fed with 4% and 2% salt than in the group fed with 0.3% salt. Further, water intake in the group fed a 2% salt plus 3% CRT diet was significantly lower than that in the group fed with a 2% salt diet.</p><p><strong>Conclusions: </strong>Dahl salt-sensitive rats fed a 2% salt diet were candidates for a model of nocturnal polyuria. Using this model, we suggest that CRT reduces water intake in the active phase and contributes to water restriction in the treatment of nocturnal polyuria.</p>","PeriodicalId":18028,"journal":{"name":"LUTS: Lower Urinary Tract Symptoms","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39891284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信